Showing results (1-10 of 173) with videos related to
Sort By:
Pageof 18
Ochsner Journal|March 28, 2013
Stimulators of soluble guanylyl cyclase: future clinical indicationsBobby D Nossaman, Philip J KadowitzCurrent Drug Discovery Technologies|March 12, 2009
The role of the RhoA/rho-kinase pathway in pulmonary hypertensionBobby D Nossaman, Philip J KadowitzThe Open Pharmacology Journal|March 24, 2009
Potential Benefits of PeroxynitriteBobby D Nossaman, Philip J KadowitzCurrent Gene Therapy|April 14, 2007
Gene and stem cell therapy in the treatment of erectile dysfunction and pulmonary hypertension; potential treatments for the common problem of endothelial dysfunctionBobby D Nossaman, Serap Gur, Philip J KadowitzCardiology in Review|June 12, 2010
Nitrates and nitrites in the treatment of ischemic cardiac diseaseVaughn E Nossaman, Bobby D Nossaman, Philip J KadowitzCardiology in Review|February 18, 2010
New approaches to the treatment of pulmonary hypertension: from bench to bedsideSubramanyam N Murthy, Bobby D Nossaman, Philip J KadowitzAnesthesiology Clinics|November 16, 2010
Advances in perioperative pain management: use of medications with dual analgesic mechanisms, tramadol & tapentadolVaughn E Nossaman, Usha Ramadhyani, Philip J Kadowitz, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|March 31, 2012
Impaired vasodilation in the pathogenesis of hypertension: focus on nitric oxide, endothelial-derived hyperpolarizing factors, and prostaglandinsThomas D Giles, Gary E Sander, Bobby D Nossaman, et al.Canadian Journal of Physiology and Pharmacology|February 5, 2010
Role of the RhoA/Rho-kinase pathway in the regulation of pulmonary vasoconstrictor functionBobby D Nossaman, Vaughn E Nossaman, Subramanyam N Murthy, et al.Journal of Clinical Rheumatology & Musculoskeletal Medicine|April 30, 2013
Pulmonary Arterial Hypertension-A Deadly Complication of Systemic SclerosisEdward A Pankey, Matthew Epps, Bobby D Nossaman, et al.Pageof 18